Africa’s regulatory landscape for genome editing has shifted from process-based to product-based frameworks. This evolution marks a pivotal change where the focus is now on the safety and efficacy of the final biotech products, rather than the methods used to create them. This aligns with public concerns and global best practices, helps foster trust, and encourages innovation while ensuring robust safety standards – a crucial step in expanding Africa’s role in global biotechnology